IRIS
GIANNINI, ALESSIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.230
EU - Europa 1.967
AS - Asia 701
SA - Sud America 151
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 5.090
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.202
RU - Federazione Russa 455
GB - Regno Unito 453
IT - Italia 304
IE - Irlanda 239
SG - Singapore 213
CN - Cina 183
SE - Svezia 128
BR - Brasile 126
FR - Francia 100
DE - Germania 94
HK - Hong Kong 77
VN - Vietnam 75
UA - Ucraina 58
IN - India 49
FI - Finlandia 38
ES - Italia 33
ZA - Sudafrica 25
TR - Turchia 18
BD - Bangladesh 15
CA - Canada 15
BE - Belgio 13
NL - Olanda 13
PL - Polonia 10
IR - Iran 8
JP - Giappone 8
UZ - Uzbekistan 8
AR - Argentina 7
GR - Grecia 7
MX - Messico 7
SA - Arabia Saudita 7
KR - Corea 6
CZ - Repubblica Ceca 5
IQ - Iraq 5
EG - Egitto 4
NG - Nigeria 4
PY - Paraguay 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AT - Austria 3
EC - Ecuador 3
ID - Indonesia 3
OM - Oman 3
PK - Pakistan 3
PT - Portogallo 3
BO - Bolivia 2
CO - Colombia 2
DO - Repubblica Dominicana 2
HN - Honduras 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MA - Marocco 2
MY - Malesia 2
PE - Perù 2
PS - Palestinian Territory 2
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
LV - Lettonia 1
MN - Mongolia 1
PH - Filippine 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TM - Turkmenistan 1
TN - Tunisia 1
Totale 5.090
Salva come PNG Salva come JPEG
Città #
Southend 398
Dallas 337
Dublin 238
Fairfield 234
Ashburn 154
Chandler 147
Moscow 135
Singapore 106
San Jose 102
Woodbridge 91
Santa Clara 88
Beijing 86
Cambridge 80
Houston 80
Seattle 80
Hong Kong 72
Siena 70
Ann Arbor 68
Wilmington 67
New York 50
Jacksonville 49
Princeton 39
Munich 38
Los Angeles 35
Ho Chi Minh City 27
Helsinki 25
Johannesburg 24
Rome 24
Milan 23
Lauterbourg 21
Málaga 21
Council Bluffs 19
San Mateo 16
Atlanta 15
Boardman 15
Dearborn 14
Hanoi 14
Brussels 13
São Paulo 13
Bengaluru 12
The Dalles 12
Izmir 11
Nanjing 11
San Diego 11
Fremont 10
Portsmouth 10
Buffalo 9
Manchester 9
Montreal 9
Chennai 8
London 8
Orem 8
Redwood City 8
Tashkent 8
Amsterdam 7
Düsseldorf 7
Frankfurt am Main 7
Mumbai 7
Redondo Beach 7
Tokyo 7
Espoo 6
Indianapolis 6
Seoul 6
Warsaw 6
Belo Horizonte 5
Brasília 5
Brescia 5
Brooklyn 5
Clifton 5
Da Nang 5
North Bergen 5
Rio de Janeiro 5
Riyadh 5
Shanghai 5
Abuja 4
Cagliari 4
Cairo 4
Changsha 4
Chicago 4
Dhaka 4
Florence 4
Jinan 4
Nanchang 4
Newark 4
Oklahoma City 4
Phoenix 4
Roccagorga 4
Salamanca 4
San Francisco 4
Tianjin 4
Toronto 4
Turku 4
Baghdad 3
Brno 3
Chongqing 3
Como 3
Fort Worth 3
Haiphong 3
Hebei 3
Istanbul 3
Totale 3.484
Salva come PNG Salva come JPEG
Nome #
Agreement between an in-house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV-1 protease, reverse transcriptase, and integrase inhibitors 326
Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 Strains 299
DDX3X inhibitors, an effective way to overcome HIV-1 resistance 298
The HIV-1 reverse transcriptase E138A natural polymorphism decreases the genetic barrier to resistance to etravirine in vitro 296
Comparable in vitro activity of second-generation HIV-1 integrase strand transfer inhibitors (INSTIs) on HIV-1 clinical isolates with INSTI resistance mutations 296
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 292
(Thia)calixarenephosphonic Acids as Potent Inhibitors of the Nucleic Acid Chaperone Activity of the HIV-1 Nucleocapsid Protein with a New Binding Mode and Multitarget Antiviral Activity 285
5,6-Dihydroxypyrimidine Scaffold to Target HIV-1 Nucleocapsid Protein 261
Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro 254
Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood 253
Performance of Geno2Pheno[coreceptor] to infer coreceptor use in human immunodeficiency virus type 1 (HIV-1) subtype A 250
Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro 239
In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations 237
The HIV-1 integrase E157Q polymorphism per se does not alter susceptibility to raltegravir and dolutegravir in vitro 234
Synthesis and Evaluation of Bifunctional Aminothiazoles as Antiretrovirals Targeting the HIV-1 Nucleocapsid Protein 229
Identification of novel 2-benzoxazolinone derivatives with specific inhibitory activity against the HIV-1 nucleocapsid protein 211
HIV drug discovery and resistance testing through cell based assays 207
Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication. 200
In vitro susceptibility to fostemsavir is not affected by long-term exposure to antiviral therapy in MDR HIV-1-infected patients 188
External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy 161
In vitro susceptibility of HIV-1 CRF02_AG to temsavir, the active compound of the attachment inhibitor fostemsavir 140
null 32
Totale 5.188
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.468
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.468
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 0 0 0 0 0 32
2021/2022482 26 59 35 51 34 28 31 28 28 42 41 79
2022/2023464 29 76 57 52 30 82 24 31 32 27 18 6
2023/2024414 14 6 35 35 4 109 139 15 1 4 5 47
2024/2025708 19 28 119 33 72 46 30 59 78 35 79 110
2025/20261.671 94 213 273 230 410 48 148 53 56 79 35 32
Totale 5.188